Evidence map›Paper›PMID 41036103›Full record

ArticleMolecular therapy. Methods & clinical development2025

Functional, sustained recovery of hearing in Otoferlin-deficient mice using DB-OTO, a hair-cell-specific AAV-based gene therapy.

Yoojin Chung, Seth D Koehler, Sarah Cancelarich, Tyler M Gibson, Gabriela Pregernig, Lars Becker, Quynh-Anh Artinian, Joseph W Goodliffe, Ning Pan, Tera M Quigley and 18 more

Abstract read
In one paragraph

Article in Molecular therapy. Methods & clinical development, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. A Structural Variant in the 5' Regulatory Region ofInternational archives of otorhinolaryngology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Yoojin ChungRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Seth D KoehlerRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Sarah CancelarichRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Tyler M GibsonDecibel Therapeutics, Inc., Boston, MA 02215, USA.
Gabriela PregernigRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Lars BeckerRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Quynh-Anh ArtinianDecibel Therapeutics, Inc., Boston, MA 02215, USA.
Joseph W GoodliffeRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Ning PanRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Tera M QuigleyRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Arun SenapatiDecibel Therapeutics, Inc., Boston, MA 02215, USA.
Peter G SladeRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Lillian M SmithDecibel Therapeutics, Inc., Boston, MA 02215, USA.
Kathy S SoRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Xichun ZhangDecibel Therapeutics, Inc., Boston, MA 02215, USA.
C Eduardo CorralesRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Peter WeberBoston Medical Center, Boston, MA 02118, USA.
Lynn E MacdonaldRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Brian ZambrowiczRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Aris N EconomidesRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Christos A KyratsousRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Joseph C BurnsDecibel Therapeutics, Inc., Boston, MA 02215, USA.
Adam T PalermoDecibel Therapeutics, Inc., Boston, MA 02215, USA.
Leah R SabinRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
John LeeRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Vassili ValayannopoulosRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Jonathon P WhittonRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Meghan C DrummondRegeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biallelic loss-of-function variants in the

Indexed as

AAVauditory neuropathyDB-OTOdeafnessDFNB9dual vectorgene therapyhearing lossotofotoferlin

Identifiers

PMID41036103
PMCPMC12481892

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.